Key facts
- It has raised $7.7M; the latest was Later Stage VC ($7.7M) in May 2025.
- Notable investors include Korea Credit Guarantee Fund, Smilegate Investment, Murex Partners, Woori Venture Partners, COMEUP STARS — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Cure Stream
- ·The full record, as it builds
Funding rounds
No funding rounds for Cure Stream are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cure Stream
Operator of a laboratory intended for researching and developing future medical treatments for chronic diseases such as diabetes. The company develops a fully autonomous artificial pancreas system based on an artificial intelligence-based hormone injection decision algorithm, enabling patients to improve the quality of life caused by diseases.
- Sector
- Healthcare
- HQ
- Daegu, South Korea
- Founded
- 2019
- Employees
- 20
- Website
- curestream.co.kr/
- Ownership
- Privately Held (backing)
Cure Stream doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cure Stream shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cure Stream in its N-PORT filings yet. We sweep new filings monthly.